For the quarter ended September 2026, Clorox (CLX Quick QuoteCLX - Free Report) reported revenue of $1.91 billion, up 33.3% over the same period last year. EPS came in at $1.55, compared to $0.85 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $1.87 billion, representing a surprise of +1.73%. The company delivered an EPS surprise of +59.79%, with the consensus EPS estimate being $0.97.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Clorox performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Organic sales growth: 18% compared to the 16.2% average estimate based on four analysts.
• Organic sales growth - Lifestyle: 16% versus the four-analyst average estimate of 15.5%.
• Organic sales growth - International: 9% versus 4.5% estimated by four analysts on average.
• Organic sales growth - Household: 17% versus 14% estimated by three analysts on average.
• Organic sales growth - Health and Wellness: 23% compared to the 33% average estimate based on three analysts.
• Net Sales- Health and Wellness: $918 million versus the four-analyst average estimate of $904.24 million. The reported number represents a year-over-year change of +62.5%.
• Net Sales- International: $281 million versus $269.3 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +11.1% change.
• Net Sales- Lifestyle: $283 million versus $282.98 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +15.5% change.
• Net Sales- Household: $423 million compared to the $414.42 million average estimate based on four analysts. The reported number represents a change of +16.9% year over year.
• Income before income taxes- Health and Wellness: $209 million versus the two-analyst average estimate of $193.06 million.
• Income before income taxes- Corporate and Other: $-46 million compared to the $-80.73 million average estimate based on two analysts.
• Income before income taxes- International: $31 million versus the two-analyst average estimate of $23.56 million.

View all Key Company Metrics for Clorox here>>>

Shares of Clorox have returned +9.4% over the past month versus the Zacks S&P 500 composite's -0.9% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.